Analyst Ratings for Mednax Inc. (MD)

Updated: 2017-07-26

Shares of Mednax Inc. (NYSE:MD) have received a consensus rating of Hold from Wall Street analysts. A consensus rating of Hold was previously issued for MD last month.

Of the 14 analysts covering the stock, 2 gave it a buy rating, 0 gave an overweight rating, 11 issued a hold rating, 1 gave an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 0. Meanwhile, the number of analysts pessimistic about the company has increased by 0.

A number of analysts gave price targets for MD. The highest price target was 68, implying potential capital gains of 20.06 percent. The minimum price target given was 53, implying a possible loss of -6.43 percent. Note that investment analysts can be biased in their reporting on companies's ratings and price targets.

In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0 percent. That number becomes -16.86 percent if we expand the time horizon to include the past 3 months instead of just one. Meanwhile, fiscal year estimates have been revised downwards by -0.72 percent, compared to last month. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -13.41 percent.

Another thing investors often look at is the level of agreement among analysts' revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, which can be compared to the 0 analysts that decreased their estimates. Also over the last month, 0 analysts increased their estimates for the FY earnings, compared to 2 analysts that revised their FY estimates downwards.

Analysts estimate earnings of MD to grow at a rate of -1.81 percent. Another measure frequently examined by investors is the PEG ratio. Smaller PEG ratios are desirable, as that can indicate whether the high price level of a stock is warranted by high growth. People often look for the PEG ratio to be under 1, but many choose to perform ratio comparisons with other companies in the industry. The PEG ratio of MD is -9.31.

In the trailing 52-weeks, MD hit 75.83 at the highest peak, while it's lowest trading point was 53.80. The current market price is above the trailing year's low by 5.28 percent, and 25.31 percent lower than its 52-week high. MD has a price/earnings ratio of 16.86. Investors typically compare the P/E ratio to a company's peers in the industry. The MD value stock report compares MD to some of its peers using value stock charts. The market cap of MD is $5.33 billion. MD will post this quarters earnings in days, on 0000-00-00.